CompletedPhase 2NCT00379431
A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab
Studying Systemic sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Ghent
- Principal Investigator
- Filip De Keyser, MD, PhDUniversity Hospital, Ghent
- Intervention
- Administration of rituximab and methylprednisolone(drug)
- Enrollment
- 9 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2006 – 2009
Study locations (4)
- UCL St. Luc Brussel, Brussels, Belgium
- UZ Brussel, Brussels, Belgium
- University Hospital Ghent, Ghent, Belgium
- UZ Gasthuisberg Leuven, Leuven, Belgium
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00379431 on ClinicalTrials.govOther trials for Systemic sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07402226Systemic Sclerosis DIet for GastrointESTinal SymptomsUniversity of Michigan
- RECRUITINGEARLY PHASE1NCT07355972Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSCUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGNANCT07360808Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic SclerosisCytori Therapeutics
- RECRUITINGNCT07228429Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography ImagesYale University
- RECRUITINGPHASE1NCT07167537A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune DiseasesBeijing GoBroad Hospital
- RECRUITINGEARLY PHASE1NCT07000682The Clinical Study on the Treatment of SSc With UTAA91 Injection.Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGNCT06865118Home-Based Clinical Management of Cardiac Complications in Systemic SclerosisOslo University Hospital
- RECRUITINGNANCT06675344The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of LifeRobyn T. Domsic, MD, MPH